Evidence map›Paper›PMID 42631253›Full record

ArticleACS electrochemistry2026

FRET-Enhanced Optical Imaging of Nanoparticle Collision on a Gold Ultramicroelectrode.

Wenyu Huang, Bo Zhang

Abstract read
In one paragraph

Article in ACS electrochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Wenyu HuangDepartment of Chemistry, University of Washington, Seattle, Washington 98195-1700, United States.ORCID 0009-0003-4594-4849
Bo ZhangDepartment of Chemistry, University of Washington, Seattle, Washington 98195-1700, United States.ORCID 0000-0002-1737-1241

Funding

A Bipolar Electrochemical Single Entity BioanalyzerR21GM149994 · NIGMS · UNIVERSITY OF WASHINGTON · PI ZHANG, BO · 2023 to 2024
$397k
NIGMS NIH HHS R21 GM149994
6 · The paper itself

Abstract

While optical imaging can help better study nanoparticle collision electrochemistry, it remains challenging to establish an optical signal that can directly reflect the redox state of individual particles during their transient collision process. Herein, we report a method based on the use of Förster resonance energy transfer (FRET) for enhancing the optical contrast of nanoparticle collision events on a gold ultramicroelectrode (UME). We first showed that methylene blue (MB), a redox-active fluorophore, exhibits fluorescence turn-off upon reduction on the electrode. To further amplify the optical signal, MB was used as a FRET acceptor and paired with Rhodamine 101 (R101) as the donor, such that MB quenches R101 emission via energy transfer, while reduced MB would disrupt this process, leading to the recovery of R101's fluorescence emission. Using polystyrene nanoparticles (PSNPs) labeled with both R101 and MB, we demonstrated fluorescence imaging of nanoparticle collision events on an Au UME, where individual particles exhibited fluorescence turn-on of R101 emission upon collision owing to the electrochemical reduction of surface-bound MB. Compared with direct imaging in the MB channel, the FRET readout provided substantially higher optical contrast and enabled clearer visualization of single-particle electrochemical processes. This work demonstrates a useful fluorescence transduction strategy for improving optical tracking in nanoparticle collision electrochemistry.

Indexed as

fluorescence imagingFRETmethylene bluenanoimpact electrochemistrysingle-entity electrochemistry

Identifiers

PMID42631253
PMCPMC13496260

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.